Speakers

Amy Hebbard, PharmD, BCPP
Amy Hebbard, PharmD, BCPP
Psychopharmacology MythBusters
Austin R. Campbell, PharmD, BCPP
Austin R. Campbell, PharmD, BCPP
Moving Beyond the Dopamine Hypothesis: An Overview of Emerging Treatment Options in Schizophrenia
Brittany Weger
Brittany Weger
Award Platform Presentations
Carolanne Wartman, PharmD, BCPS
Carolanne Wartman, PharmD, BCPS
Award Platform Presentations
Carolina Liriano, PharmD
Carolina Liriano, PharmD
Clinical Pearls
Carolyn O’Donnell, PharmD
Carolyn O’Donnell, PharmD
Award Platform Presentations
Casey Tiefenthaler, PharmD
Casey Tiefenthaler, PharmD
Award Platform Presentations
Chris Celano, MD, FACLP
Chris Celano, MD, FACLP
Don’t Go Breakin’ My Heart: Managing Depression and Anxiety in Cardiac Patients
Christie Costello, PharmD, BCPS
Christie Costello, PharmD, BCPS
Award Platform Presentations
Christina Aquilante, PharmD, FCCP
Christina Aquilante, PharmD, FCCP
Pharmacogenomics for Depression: What We Know and What is Needed
Daniel O. Claassen, MD
Daniel O. Claassen, MD
Diagnostic and Treatment Options for Psychosis in Lewy Body and Parkinson Disease
Deanna Kelly, PharmD, BCPP
Deanna Kelly, PharmD, BCPP
Product Theater The Role of Antipsychotic TDM in Clinical Decision Making: The Example of Clozapine Supported by Saladax
Barriers and Benign Ethnic Neutropenia: Improving Use of Clozapine in Black Patients
Devon Sherwood, PharmD, BCPP
Devon Sherwood, PharmD, BCPP
The Use of Simulations in Psychiatric Education
Ganesh Gopalakrishna, MD, MHA
Ganesh Gopalakrishna, MD, MHA
Alzheimer’s Disease: Treatment and Targets
George Brown, MD, DFAPA
George Brown, MD, DFAPA
Implications of Hormonal Treatment for the Transgender Patient
Haley Pals, PharmD
Haley Pals, PharmD
Award Platform Presentations
Ian McGrane, PharmD, BCPP
Ian McGrane, PharmD, BCPP
Award Platform Presentations
J. Michael McGuire, PharmD, BCPP
J. Michael McGuire, PharmD, BCPP
Serotonin Receptors Update
Jacintha Cauffield, PharmD, BCPS, CDCES, CRPS-A
Jacintha Cauffield, PharmD, BCPS, CDCES, CRPS-A
Applying Lived Experience with a Mental Health Condition to a Health Professional Role
Jacob Hanaie, PharmD, APH
Jacob Hanaie, PharmD, APH
Product Theater and Lunch Learn More: An oral Treatment Option for Adults with Schizophrenia or Bipolar I Disorder Supported by Alkermes
Jeffrey Newport, MD, MS, MDiv
Jeffrey Newport, MD, MS, MDiv
Evaluating the Evidence for Reproductive Safety of Psychotropic Medications
Joel C. Marrs, PharmD, MPH, BCACP, BCCP, BCPS, CHC, CLS, FAHA, FASHP, FCCP, FNLA
Joel C. Marrs, PharmD, MPH, BCACP, BCCP, BCPS, CHC, CLS, FAHA, FASHP, FCCP, FNLA
Pre-Meeting Workshop: Hands-on Approach to Cardiovascular Disease Risk Management for People Living with Mental Illness
Jonathan Leung, PharmD, BCPS, BCPP
Jonathan Leung, PharmD, BCPS, BCPP
Atypical Side Effects of Clozapine: A Focus on Inflammation
Jonathan Meyer, MD
Jonathan Meyer, MD
Industry Symposium with ACPE Credit and Breakfast Keeping the Body in Mind: Metabolic Effects of Antipsychotic Medications Supported by Intra-Cellular
Product Theater The Role of Antipsychotic TDM in Clinical Decision Making: The Example of Clozapine Supported by Saladax
Joseph Cusimano, PharmD, BCPP
Joseph Cusimano, PharmD, BCPP
Clinical Pearls
Kathryn Comanici, PharmD
Kathryn Comanici, PharmD
Award Platform Presentations
Kristin Bohnenberger, PharmD, DABAT
Kristin Bohnenberger, PharmD, DABAT
Designer Downers: Novel Benzodiazepines
Kristin Waters, PharmD, BCPS, BCPP
Kristin Waters, PharmD, BCPS, BCPP
Product Theater and Lunch Delaying Time to Relapse in Adult Patients With Schizophrenia Supported by Janssen Pharmaceuticals, Inc.
Laura Miller, MD
Laura Miller, MD
Understanding and Treating Attention-Deficit/Hyperactivity Disorder (ADHD) during Pregnancy and Postpartum
Logan Smith
Logan Smith
Award Platform Presentations
Megan Ehret, PharmD, MS, BCPP
Megan Ehret, PharmD, MS, BCPP
Product Theater The Role of Antipsychotic TDM in Clinical Decision Making: The Example of Clozapine Supported by Saladax
Megan Maroney, PharmD, BCPP
Megan Maroney, PharmD, BCPP
Industry Symposium with ACPE Credit and Breakfast Treatment Advancements to Overcome Barriers in the Management of Schizophrenia: Key Considerations for Pharmacists Supported by Alkermes
Michael Lutter, MD, PhD
Michael Lutter, MD, PhD
Evaluation and Management of Eating Disorders
Rob Cotes, MD
Rob Cotes, MD
Product Theater The Role of Antipsychotic TDM in Clinical Decision Making: The Example of Clozapine Supported by Saladax
Roger Sommi, PharmD, BCPP, FCCP
Roger Sommi, PharmD, BCPP, FCCP
Emerging Role of Orexins in Psychiatry
Sally Arif, PharmD, BCPS, BCCP
Sally Arif, PharmD, BCPS, BCCP
Racial and Health Disparities in Psychiatry and the Role of the Pharmacist
Sandra Mullen, PharmD, BCPP
Sandra Mullen, PharmD, BCPP
Treatment Challenges in the Management of Tourette’s Disorder
Sarah Anderson PharmD, BCACP, BCPS, FASHP, FCCP
Sarah Anderson PharmD, BCACP, BCPS, FASHP, FCCP
Pre-Meeting Workshop: Hands-on Approach to Cardiovascular Disease Risk Management for People Living with Mental Illness
Shadi Doroudgar, PharmD, APh, BCPS, BCGP, BCPP
Shadi Doroudgar, PharmD, APh, BCPS, BCGP, BCPP
Clinical Pearls
Stephanie Nichols, PharmD, BCPS, BCPP, FCCP
Stephanie Nichols, PharmD, BCPS, BCPP, FCCP
The Use of Simulations in Psychiatric Education
Stephen R. Saklad, PharmD, BCPP
Stephen R. Saklad, PharmD, BCPP
Psychiatric and Neurologic Medication Pipeline
Thomas Insel, MD
Thomas Insel, MD
The Way Forward: Our Path from Mental Illness to Mental Health
Troy Moore, PharmD, MS, BCCP
Troy Moore, PharmD, MS, BCCP
Outpatient Management of Alcohol Withdrawal
William Eggleston, PharmD, DABAT
William Eggleston, PharmD, DABAT
Emerging Trends in Substance Use